{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-183310","form_type":"8-K","ticker":"BHC","cik":"0000885590","company_name":"Bausch Health Companies Inc.","filed_at":"2023-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.876561+00:00","generated_at":"2026-06-13T11:24:20.726023+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bausch Health enters $600M non-recourse receivables financing with KKR","bullets":["$600M revolving credit facility collateralized by accounts receivables, matures January 28, 2028.","Interest at 1-month Term SOFR plus 6.65%; proceeds for general corporate purposes.","Facility is non-recourse to Bausch Health, structured through subsidiary Bausch Receivables Funding LP.","KKR acted as left lead arranger and structuring advisor; Houlihan Lokey financial advisor.","Facility provides approximately five-year term liquidity; Finacity Corporation as program administrator."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-183310","json":"https://secwatch.observer/filing/0001193125-23-183310.json","markdown":"https://secwatch.observer/filing/0001193125-23-183310.md","text":"https://secwatch.observer/filing/0001193125-23-183310.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885590/000119312523183310/0001193125-23-183310-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885590/000119312523183310/d478804d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T11:24:20.726023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac0893123ccbac2391f3fd71af9f5ec754d2a049","claim":"Bausch Health Companies Inc. incurred revolving credit of $600 million with GLAS USA LLC (Administrative Agent) and the Lenders from time to time party thereto at one month Term SOFR plus 6.65% maturing January 28, 2028.","evidence_excerpt":"The Credit Agreement provides for a $600 million revolving credit facility (the “Revolving Credit Facility”), subject to certain borrowing base tests, which matures on January 28, 2028. Loans under the Revolving Credit Facility bear interest at a rate equal to the sum of one month Term SOFR plus 6.65%.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/885590/000119312523183310/0001193125-23-183310-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$600 million"},{"label":"Counterparty","value":"GLAS USA LLC (Administrative Agent) and the Lenders from time to time party thereto"},{"label":"Rate","value":"one month Term SOFR plus 6.65%"},{"label":"Maturity","value":"January 28, 2028"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}